Related Experiment Video
Updated: Aug 16, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
Pulmonary complications in amiodarone treatment
Adam Podstawka1, Jerzy Mosiewicz, Wojciech Myśliński
1Ward of Pulmonary Diseases and Phthisiology Independent Public Hospital named after John of God in Lublin.
Abstract:
Amiodarone is a widely used antiarrhythmic drug, however, not without numerous side-effects. One of them is a potentially adverse reaction upon the respiratory system which can assume the form of acute respiratory failure, interstitial pneumonitis, parenchymal infiltrates, pleural effusion or bronchiolitis obliterans organizing pneumonia. For this reason prior to the onset of the long-term amiodarone therapy initial chest x-ray and spirometry should be made and in the course of the treatment spirometry and radiological monitoring should be carried out. Helpful in diagnosing the side-effects of amiodarone use in relation to the respiratory system could also be plethysmography, evaluation of the diffusing capacity, Gallium scintigraphy and cancer-associated serum antigen (CASA). While planning a long-term amiodarone therapy one should consider the risk factors of the development of pulmonary complications and the necessity to use this drug should be connected with the activities aiming at an early diagnosis of the respiratory system dysfunctions.
Related Concept Videos
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Cardiomyopathy II: Dilated Cardiomyopathy
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Coronary Artery Disease III: Clinical Manifestations
Heart Failure Drugs: Inotropic Agents